Monthly Archives: March 2015

New mechanism for engineering traits governed by multiple genes paves the way for various advances in genomics and regenerative medicine

(BOSTON) - When it comes to gene expression - the process by which our DNA provides the recipe used to direct the synthesis of proteins and other molecules that we need for development and survival - scientists have so far studied one single gene at a time. A new approach developed by Harvard geneticist George Church, Ph.D., can help uncover how tandem gene circuits dictate life processes, such as the healthy development of tissue or the triggering of a particular disease, and can also be used for directing precision stem cell differentiation for regenerative medicine and growing organ transplants.

The findings, reported by Church and his team of researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School in Nature Methods, show promise that precision gene therapies could be developed to prevent and treat disease on a highly customizable, personalized level, which is crucial given the fact that diseases develop among diverse pathways among genetically-varied individuals. Wyss Core Faculty member Jim Collins, Ph.D., was also a co-author on the paper. Collins is also the Henri Termeer Professor of Medical Engineering & Science and Professor in the Department of Biological Engineering at the Massachusetts Institute of Technology.

The approach leverages the Cas9 protein, which has already been employed as a Swiss Army knife for genome engineering, in a novel way. The Cas9 protein can be programmed to bind and cleave any desired section of DNA - but now Church's new approach activates the genes Cas9 binds to rather than cleaving them, triggering them to activate transcription to express or repress desired genetic traits. And by engineering the Cas9 to be fused to a triple-pronged transcription factor, Church and his team can robustly manipulate single or multiple genes to control gene expression.

"In terms of genetic engineering, the more knobs you can twist to exert control over the expression of genetic traits, the better," said Church, a Wyss Core Faculty member who is also Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and MIT. "This new work represents a major, entirely new class of knobs that we could use to control multiple genes and therefore influence whether or not specific genetics traits are expressed and to what extent - we could essentially dial gene expression up or down with great precision."

Such a capability could lead to gene therapies that would mitigate age-related degeneration and the onset of disease; in the study, Church and his team demonstrated the ability to manipulate gene expression in yeast, flies, mouse and human cell cultures.

"We envision using this approach to investigate and create comprehensive libraries that document which gene circuits control a wide range of gene expression," said one of the study's lead authors Alejandro Chavez, Ph.D., Postdoctoral Fellow at the Wyss Institute. Jonathan Schieman, Ph.D, of the Wyss Institute and Harvard Medical School, and Suhani Vora, of the Wyss Institute, Massachusetts Institute of Technology, and Harvard Medical School, are also lead co-authors on the study.

The new Cas9 approach could also potentially target and activate sections of the genome made up of genes that are not directly responsible for transcription, and which previously were poorly understood. These sections, which comprise up to 90% of the genome in humans, have previously been considered to be useless DNA "dark matter" by geneticists. In contrast to translated DNA, which contains recipes of genetic information used to express traits, this DNA dark matter contains transcribed genes which act in mysterious ways, with several of these genes often having influence in tandem.

But now, that DNA dark matter could be accessed using Cas9, allowing scientists to document which non-translated genes can be activated in tandem to influence gene expression. Furthermore, these non-translated genes could also be turned into a docking station of sorts. By using Cas9 to target and bind gene circuits to these sections, scientists could introduce synthetic loops of genes to a genome, therefore triggering entirely new or altered gene expressions.

The ability to manipulate multiple genes in tandem so precisely also has big implications for advancing stem cell engineering for development of transplant organs and regenerative therapies.

The rest is here:
Activating genes on demand

FRESNO, Calif. (KFSN) --

Five-year-old Elizabeth Eastham has just finished a round of chemotherapy to treat kidney cancer. It's a tough battle, but Elizabeth's mom knows today's discoveries may bring tomorrow's hope.

"With what they find with your child can help another child later on would be fantastic," Elizabeth's mother, Angela Eastham told ABC30.

Dr. Hao Zhu is researching how pediatric cancers develop on the genetic level. He's pinpointed a gene that contributes to childhood cancers like neuroblastoma, Wilms tumor and liver cancer.

"And what we hope to do is to discover specific genetic targets for novel drugs to kill cancers without hurting the rest of the body," Hao Zhu, M.D., Assistant Professor Children's Research Institute at UT Southwestern told ABC30.

In laboratory mice, Dr. Zhu has found that the lin28 gene, which normally contributes to embryonic growth, also plays a role in cancer formation in fully developed juveniles.

Dr. Zhu explained, "We hope one day to be able to treat and diagnose cancers better in children."

"You don't want this for your child," said Eastham. "But you know that everything is in God's plan, and you know he saw us through this entire process and kept our strength up, and everyone's strength up around us to keep going and face one day at a time."

It may be years from the laboratory to the patient, but this discovery, published in the journal Cancer Cell, gives researchers hope that understanding how cancer works will lead to better treatments for children in the future.

For more information on this report, please contact:

More here:
Cancer gene: Medicine's next big thing?